- Q4 2023 Sangamo Therapeutics Inc Earnings Call TranscriptMar 13, 2024$0.8008 (-5.87%)Earnings
- Q3 2023 Sangamo Therapeutics Inc Earnings Call TranscriptNov 02, 2023$0.4755 (-13.97%)Earnings
- Q2 2023 Sangamo Therapeutics Inc Earnings Call TranscriptAug 08, 2023$1.14 (-2.56%)Earnings
- Sangamo Therapeutics Inc at Barclays Virtual Gene Editing & Therapy Summit TranscriptMay 24, 2023
- Sangamo Therapeutics Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2023
- Sangamo Therapeutics Inc at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
- Q1 2023 Sangamo Therapeutics Inc Earnings Call TranscriptApr 27, 2023$1.66 (+3.99%)Earnings
- Sangamo Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Q4 2022 Sangamo Therapeutics Inc Earnings Call TranscriptFeb 22, 2023$2.92Earnings
- Sangamo Therapeutics Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptDec 01, 2022
- Sangamo Therapeutics Inc at Credit Suisse Healthcare Conference TranscriptNov 08, 2022
- Q3 2022 Sangamo Therapeutics Inc Earnings Call TranscriptNov 03, 2022$4.26 (-3.60%)Earnings
- Q2 2022 Sangamo Therapeutics Inc Earnings Call TranscriptAug 04, 2022$4.78Earnings
- Sangamo Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 09, 2022
- Sangamo Therapeutics Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptMay 24, 2022
- Sangamo Therapeutics Inc at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Q1 2022 Sangamo Therapeutics Inc Earnings Call TranscriptMay 05, 2022$4.35 (+1.83%)Earnings
- Sangamo Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 17, 2022
- Q4 2021 Sangamo Therapeutics Inc Earnings Call TranscriptFeb 24, 2022$5.44 (-1.31%)Earnings
- Sangamo Therapeutics Inc at Barclays Gene Editing & Gene Therapy Summit (Virtual) TranscriptNov 15, 2021
- Q3 2021 Sangamo Therapeutics Inc Earnings Call TranscriptNov 04, 2021$11.03 (+20.41%)Earnings
- Sangamo Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2021
- Q2 2021 Sangamo Therapeutics Inc Earnings Call TranscriptAug 05, 2021$9.76 (+1.99%)Earnings
- Sangamo Therapeutics Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 04, 2021
- Sangamo Therapeutics Inc Annual Shareholders Meeting TranscriptMay 25, 2021
- Sangamo Therapeutics Inc at RBC Capital Markets Global Healthcare Conference (Virtual) TranscriptMay 18, 2021
- Sangamo Therapeutics Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 13, 2021
- Q1 2021 Sangamo Therapeutics Inc Earnings Call TranscriptMay 04, 2021$11.3 (-4.48%)Earnings
- Sangamo Therapeutics Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 10, 2021
- Sangamo Therapeutics Inc at H C Wainwright Global Life Sciences Conference (Virtual) TranscriptMar 09, 2021
- Q4 2020 Sangamo Therapeutics Inc Earnings Call TranscriptFeb 24, 2021$12.57 (+6.24%)Earnings
- Sangamo Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2021
- Sangamo Therapeutics Inc at Barclays Virtual Gene Editing & Gene Therapy Summit TranscriptNov 16, 2020
- Sangamo Therapeutics Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 09, 2020
- Q3 2020 Sangamo Therapeutics Inc Earnings Call TranscriptNov 04, 2020$10.43Earnings
- Sangamo Therapeutics Inc at Chardan Genetic Medicines Conference (Virtual) TranscriptOct 05, 2020
- Sangamo Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 18, 2020
- Q2 2020 Sangamo Therapeutics Inc Earnings Call TranscriptAug 05, 2020$10.58Earnings
- Sangamo Therapeutics Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 02, 2020
- Sangamo Therapeutics Inc Annual Shareholders Meeting TranscriptMay 18, 2020
- Sangamo Therapeutics Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 14, 2020
- Q1 2020 Sangamo Therapeutics Inc Earnings Call TranscriptMay 11, 2020$7.27Earnings
- Sangamo Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 11, 2020
- Q4 2019 Sangamo Therapeutics Inc Earnings and Collaboration Agreement with Biogen Inc Call TranscriptFeb 28, 2020
- Sangamo Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 16, 2020
- Sangamo Therapeutics Inc R&D Day TranscriptDec 17, 2019
- Q3 2019 Sangamo Therapeutics Inc Earnings Call TranscriptNov 06, 2019$9.07Earnings
- Sangamo Therapeutics Inc at Jefferies Gene Therapy/Editing Summit TranscriptOct 08, 2019
- Sangamo Therapeutics Inc at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Q2 2019 Sangamo Therapeutics Inc Earnings Call TranscriptAug 07, 2019$12.17Earnings
- Sangamo Therapeutics Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 15, 2019
- Q1 2019 Sangamo Therapeutics Inc Earnings Call TranscriptMay 08, 2019$13.28Earnings
- Sangamo Therapeutics Inc Clinical Development Update Call TranscriptApr 02, 2019
- Sangamo Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 14, 2019
- Q4 2018 Sangamo Therapeutics Inc Earnings Call TranscriptFeb 28, 2019$9.11Earnings
Q2 2022 Sangamo Therapeutics Inc Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to Sangamo's Second Quarter 2022 Earnings Conference Call. (Operator Instructions) I would now like to turn the call over to your host, Louise Wilkie, you may begin.
Good afternoon. I'm Louise Wilkie, Sangamo's Vice President of Investor Relations and Corporate Communications. Thank you for joining us on the call today.
On this call are several members of the Sangamo executive leadership team, including Sandy Macrae, Chief Executive Officer; Mark McClung, Chief Operating Officer; Prathyusha Duraibabu, Chief Financial Officer; Jason Fontenot, Chief Scientific Officer; Rob Schott, Head of Development; and Bettina Cockroft, Chief Medical Officer.
Slides from our corporate presentation can be found on our website, sangamo.com, under the Investors & Media section of the Events and Presentations page. This call includes forward-looking statements regarding Sangamo's current expectations. These statements include, but are not limited to, statements relating to the therapeutic
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)